Literature DB >> 6738259

[Stroma-free hemoglobin solution and perfusion of isolated extremities].

P Hild, K Schwemmle, E Zscherpe, F Pfannkuch.   

Abstract

Pyridoxylated stroma-free hemoglobin solution was compared to hemodiluted blood in extremity perfusion of mongrel dogs. pH-values in tissue and in perfusate as well as oxygen tension showed no significant difference, and oxygen supply to the periphery was sufficient. Measurement of lactate, pyruvate, ATP and CP demonstrated domination of aerobic metabolism. We proved that stroma-free hemoglobin solution ( SFHb -PLP) can substitute hemodiluted blood (Hk 18) in isolated extremity perfusion. Metabolic results were confirmed by histological examination where no tissue alterations could be found in the perfused extremity or the whole body system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6738259     DOI: 10.1007/BF01254186

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  10 in total

1.  [The use of stroma-free hemoglobin solutions as blood substitute].

Authors:  H Förster; I Hoos; M Schneider; H Hauk
Journal:  Infusionsther Klin Ernahr       Date:  1977-04

Review 2.  The development of haemoglobin preparations for various indications.

Authors:  R Dudziak; K Bonhard
Journal:  Anaesthesist       Date:  1980-04       Impact factor: 1.041

3.  [Cardioplegic haemoglobin-perfusion for myocardial protection. Experiments on isolated rat-hearts (author's transl)].

Authors:  U Ottermann
Journal:  Anaesthesist       Date:  1980-04       Impact factor: 1.041

4.  Tissue toxicity of cis-platinum in hyperthermic isolated extremity perfusion.

Authors:  P Hild; K Aigner; K Schwemmle; K Henneking; L Illig; G Merker; M Hundeiker; E Paul; E G Weber; M Müller
Journal:  Anticancer Res       Date:  1982 Jan-Apr       Impact factor: 2.480

5.  Cytotoxics and hyperthermic perfusion: a preliminary study.

Authors:  J Tonak; P Hermanek; H Banz; H Groitl
Journal:  Cancer Treat Rev       Date:  1979-06       Impact factor: 12.111

6.  Results of hyperthermic perfusion for melanoma of the extremities.

Authors:  J S Stehlin; B C Giovanella; P D de Ipolyi; L R Muenz; R F Anderson
Journal:  Surg Gynecol Obstet       Date:  1975-03

7.  Isolated extremity perfusion with DTIC. An experimental and clinical study.

Authors:  K Aigner; P Hild; H Breithaupt; M Hundeiker; K Schwemmle; K Henneking; L Illig; G Merker; E Paul; J Brodkorb; A Jungbluth
Journal:  Anticancer Res       Date:  1983 Mar-Apr       Impact factor: 2.480

8.  Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion.

Authors:  H Schraffordt Koops; H Beekhuis; J Oldhoff; J W Oosterhuis; E van der Ploeg; A Vermey
Journal:  Cancer       Date:  1981-11-01       Impact factor: 6.860

9.  [Regional hyperthermic perfusion with cytostatic agents in malignant melanoma of the extremities (author's transl)].

Authors:  F Ghussen; K Nagel; W Groth
Journal:  Dtsch Med Wochenschr       Date:  1981-11-27       Impact factor: 0.628

10.  Chemotherapy of sarcomas of the limbs by regional perfusion.

Authors:  E T Krementz; R D Carter; C M Sutherland; I Hutton
Journal:  Ann Surg       Date:  1977-05       Impact factor: 12.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.